Breyanzi car t cell therapy to patient ENR-018564. Breyanzi 50-110M car POS t-cell CTN US. Lisocabtagene maraleucel.

Ended Awarded

Contract number
36C24925F0044
Awardee
Awarding agency
Obligated
$310,936

Award facts

Contract value 100% obligated
$310,935.67 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Lawrenceville, Lawrence Township, NJ 08648, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the delivery of BREYANZI, a chimeric antigen receptor (CAR) T-cell therapy, to patient ENR-018564. The contract was awarded to Bristol-Myers Squibb Company, a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 (VISN 9). The contract is a firm fixed price delivery order with a ceiling value of $310,935.67 and a performance period ending on January 5, 2025. This order is placed against Bristol-Myers Squibb's larger Federal Supply Schedule (FSS) contract with the VA, which has a ceiling value of $12,278,876,570.00 and runs through April 30, 2029. The contract does not have a set-aside designation, reflecting Bristol-Myers Squibb's status as a large pharmaceutical manufacturer. This award supports the VA's mission of providing cutting-edge medical care to veterans, as BREYANZI is an advanced CAR T-cell therapy used to treat certain types of non-Hodgkin lymphoma.

Quick answers

Who was awarded contract 36C24925F0044?

36C24925F0044 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 7, 2024.

How much is contract 36C24925F0044 worth?

The government has obligated $310,936 on 36C24925F0044.

Is contract 36C24925F0044 an order under another contract?

Yes. 36C24925F0044 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24925F0044 competed?

The extent of competition for 36C24925F0044 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award